Skip to content
  • Sunday, 26 July 2026
  • 12:46 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Neuroscience & Brain Research

King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286

Rifan Muazin Jul 25, 2026 0

Researchers at King’s College London have identified a promising new therapeutic strategy for Alzheimer’s disease by targeting several of the…

Read More
Neuroscience & Brain Research

Buck Institute Study Reveals How APOE2 Gene Protects Against Alzheimer’s and Promotes Longevity through DNA Repair and Senescence Resistance

Rifan Muazin Jul 24, 2026 0

For decades, the genetic landscape of Alzheimer’s disease has been dominated by the study of the apolipoprotein E (APOE) gene.…

Read More
Neuroscience & Brain Research

Lab-grown mini brains may predict which Alzheimer’s treatments will work

Rifan Muazin Jul 23, 2026 0

In a significant advancement for neurodegenerative research, scientists at Johns Hopkins Medicine have unveiled new evidence suggesting that small clusters…

Read More
Neuroscience & Brain Research

Discovery of Karyoptosis Reveals New Pathway for Brain Cell Death in Alzheimer’s and Frontotemporal Dementia

Rifan Muazin Jul 22, 2026 0

Scientists at King’s College London and the UK Dementia Research Institute have identified a previously unknown biological mechanism that explains…

Read More
Pharmaceutical R&D

Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics

Teuku Ryan Jul 22, 2026 0

The landscape of Alzheimer’s disease (AD) research and treatment is undergoing a significant transformation, marked by the recent advent of…

Read More
Neuroscience & Brain Research

Protein SORLA Identified as Critical Defense Mechanism Against Toxic Tau Tangles in Alzheimer’s Disease and Related Tauopathies

Rifan Muazin Jul 21, 2026 0

In a landmark study published on July 17, 2026, in the journal Science Advances, researchers at Sanford Burnham Prebys have…

Read More
Neuroscience & Brain Research

Brain Immune Cells Identified as Primary Driver of Alzheimer’s Related Sleep Loss in New Study

Rifan Muazin Jul 20, 2026 0

Researchers at the University of Kentucky have uncovered a pivotal mechanism in the progression of Alzheimer’s disease, identifying the brain’s…

Read More
Neuroscience & Brain Research

King’s College London Researchers Identify KCL-286 as a Multitarget Breakthrough for Early-Stage Alzheimer’s Treatment

Rifan Muazin Jul 17, 2026 0

The landscape of neurodegenerative research has shifted significantly following a landmark discovery by scientists at King’s College London (KCL), who…

Read More
Neuroscience & Brain Research

Immature Neurons and the Secret to Cognitive Resilience: New Research Explains Why Some Brains Resist Alzheimer’s Disease

Rifan Muazin Jul 16, 2026 0

The scientific community has long grappled with a biological paradox: why do some individuals maintain perfect mental clarity until the…

Read More
Environmental & Analytical Chemistry

Experimental Drug Shows Promise in Clearing Tau Tangles, Offering New Hope for Alzheimer’s Patients

Abdurrohim Arsyad Jul 15, 2026 0

LONDON – An experimental drug has demonstrated the ability to clear toxic tau tangles from the brain, a significant step…

Read More

Posts pagination

1 2 … 9
Researchers Discover Method to Manipulate Turbulent Energy Flux Challenging Decades of Established Physics TheoryBeyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity marketJohns Hopkins Researchers Uncover Molecular Mechanisms of Translocation Renal Cell Carcinoma Through the Formation of Liquid Protein CondensatesSolving the Two-Century Geological Mystery of the Dolomite Problem through Atomic Simulation and Pulsed Growth
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ